ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues

This publication has 14 references indexed in Scilit:

• Critical determination of the frequency of c-erbB-2 amplification in breast cancer
  British Journal of Cancer, 1994
• c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer
  New England Journal of Medicine, 1994
• HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples
  European Journal Of Cancer, 1993
• Die Expression des p185^neu-Onkoproteins markiert eine ungünstige Prognose bei kleinen, nodal-negativen, nicht adjuvant systemisch behandelten Mammakarzinomen (T₁N₀)
  Geburtshilfe und Frauenheilkunde, 1993
• Correlation of HER-2/neu Amplification With Expression and With Other Prognostic Factors in 1103 Breast Cancers
  JNCI Journal of the National Cancer Institute, 1992
• ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.
  Proceedings of the National Academy of Sciences, 1992
• HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
  Journal of Clinical Oncology, 1992
• Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays
  European Journal Of Cancer, 1992
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
  The Lancet, 1992
• Overexpression of the c‐erbB‐2 protein in human breast tumor cell lines
  Journal of Cellular Biochemistry, 1989